Genotyping and artificial intelligence are together starting to predict the progression of glaucoma in individual patients, sparing them from suboptimal treatments and adverse effects. Recent research efforts are exploring modifiable risk factors such as caffeine consumption.
Dr. Carel Hoyng divulges the main takeaways from his Angiogenesis presentation, including the origins of Stargardt disease, correct diagnosis, ongoing gene therapy trials and the future of therapy.
Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.
Retinal imaging tests are providing material to train and test decision-support systems.
It will soon be time for the FIL – Feira Internacional de Lisboa in Lisbon, Portugal to open its doors to the ophthalmic community for the 35th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), taking place between the 7th and 11th October 2017.